EZH2 and central nervous system cancer: ZDHHC5 contributes to the self-renewal of glioma-initiating stem cells through the palmitoylation of EZH2, activating histone H3 Lysine 27 trimethylation (H3K27me3), and driving malignant development and progression in p53-mutant gliomas.134